SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-19-009720
Filing Date
2019-05-14
Accepted
2019-05-14 06:08:07
Documents
5
Effectiveness Date
2019-05-14

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A acrx20190509_defa14a.htm DEFA14A 17007
2 notice1.jpg GRAPHIC 122162
3 notice2.jpg GRAPHIC 202013
4 notice3.jpg GRAPHIC 83637
5 notice4.jpg GRAPHIC 7449
  Complete submission text file 0001437749-19-009720.txt   582581
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35068 | Film No.: 19820337
SIC: 2834 Pharmaceutical Preparations